Noncardiogenic Pulmonary Edema in Low-dose Oral Methotrexate Therapy

この論文にアクセスする

この論文をさがす

著者

抄録

In the past two decades, low-dose methotrexate (MTX) has been widely used in the treatment of rheumatoid arthritis (RA). As adverse effects, various types of pulmonary toxicity have been reported with this therapy. We report a case of MTX-induced noncardiogenic pulmonary edema in a 35-year-old woman. MTX used in high dose for anti-cancer therapy is known to cause noncardiogenic pulmonary edema. However, there are no previous reports of noncardiogenic pulmonary edema caused by low-dose MTX therapy. This report suggests that patients receiving oral weekly, low-dose MTX may be at risk for the development of noncardiogenic pulmonary edema.

収録刊行物

  • Internal medicine

    Internal medicine 43(9), 846-851, 2004-09-01

    一般社団法人 日本内科学会

参考文献:  13件中 1-13件 を表示

各種コード

  • NII論文ID(NAID)
    10013571724
  • NII書誌ID(NCID)
    AA10827774
  • 本文言語コード
    ENG
  • 資料種別
    NOT
  • ISSN
    09182918
  • NDL 記事登録ID
    7095688
  • NDL 雑誌分類
    ZS21(科学技術--医学--内科学)
  • NDL 請求記号
    Z53-M398
  • データ提供元
    CJP書誌  NDL  J-STAGE 
ページトップへ